| Earl P Robinson Jr, MD | |
|
600 Fitch St, 202/203, Elmira, NY 14905-1634 | |
| (607) 271-3780 | |
| (607) 271-3894 |
| Full Name | Earl P Robinson Jr |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 600 Fitch St, Elmira, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992792238 | NPI | - | NPPES |
| 00419269 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | NY116344-1 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Earl P Robinson Jr, MD 571 Saint Josephs Blvd, 2nd Floor, Elmira, NY 14901-3230 Ph: (607) 271-2050 | Earl P Robinson Jr, MD 600 Fitch St, 202/203, Elmira, NY 14905-1634 Ph: (607) 271-3780 |
News Archive
Industry Standard Research (ISR) today announced the launch of a new and substantial research report titled Success in Patient and Investigator Recruitment. This report presents data and analysis from 362 interviews with Patients, Principal Investigators, and Drug development professionals from around the world.
The FDA and representatives from the medical device industry have reached an agreement in principle on proposed recommendations for the third reauthorization of a medical device user fee program.
A high percentage of children, teens and young adults with migraines appear to have mild deficiencies in vitamin D, riboflavin and coenzyme Q10 - a vitamin-like substance found in every cell of the body that is used to produce energy for cell growth and maintenance.
Patients with gastrointestinal stromal tumours (GIST) can now take action at an earlier stage of this rare form of cancer to reduce the risk of their disease returning following surgery. Novartis Pharmaceuticals Canada announced today that Gleevec* (imatinib mesylate) has received conditional approval by Health Canada for the adjuvant (post-surgical) treatment of adult patients who are at intermediate to high risk of disease recurrence following the surgical removal of GIST.
Caffeine intake by children and adolescents has been rising for decades, due in large part to the popularity of caffeinated sodas and energy drinks, which now are marketed to children as young as four.
› Verified 4 days ago
Rohail Aijaz Baig, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 600 Roe Ave, Elmira, NY 14905 Phone: 607-442-1713 | |
Dr. Franck Taghi Tirgari, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 600 Roe Ave, Elmira, NY 14905 Phone: 607-737-7770 Fax: 607-271-3686 | |
Dr. Samir Shah, DO Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 600 Roe Ave, Elmira, NY 14905 Phone: 607-737-4100 | |
Dr. James G. Freeman, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 Madison Ave, 3rd Floor, Elmira, NY 14901 Phone: 607-734-1581 Fax: 607-734-0972 | |
Dr. Keith W. Parker, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 Madison Ave Fl 3, Elmira, NY 14901 Phone: 607-734-1581 Fax: 607-734-0972 | |
Dr. Ethan Levine, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 600 Roe Ave, Elmira, NY 14905 Phone: 607-735-4623 Fax: 607-271-3711 | |
Dr. Samuel Thomas Jennings, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 600 Fitch St, Suite 202 & 203, Elmira, NY 14905 Phone: 607-271-3780 Fax: 607-271-3894 |